Direct-Acting Antiviral Medicines Market Size

Direct-Acting Antiviral Medicines Market size is likely to register remarkable growth rate during the forecast period i.e., between 2024-2036. 

Increasing prevalence of liver cirrhosis and hepatocellular carcinoma, along with the growing investment in the development of advanced therapies are expected to fuel the progress of this market. The growth of the market can also be attributed to factors such as increase in awareness for treatment and improvement in healthcare infrastructure in developing countries. According to the World Health Organization (WHO), nearly 71 million people are living with chronic hepatitis C virus infection. Of these, a large group of population developed cirrhosis or liver cancer.